Trajan Group Holdings (ASX:TRJ) Current Accrued Expense : A$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings Current Accrued Expense?

Trajan Group Holdings's Current Accrued Expense for the quarter that ended in Dec. 2023 was A$0.0 Mil.

Trajan Group Holdings Current Accrued Expense Historical Data

The historical data trend for Trajan Group Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings Current Accrued Expense Chart

Trajan Group Holdings Annual Data

Trend

Jun21

Jun22

Jun23

Current Accrued Expense

Trajan Group Holdings Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial			-	-	-	-	-

Trajan Group Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Trajan Group Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Trajan Group Holdings (ASX:TRJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (ASX:TRJ) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Argent Place, Ringwood, VIC, AUS, 3134

Website

https://www.trajanscimed.com

Trajan Group Holdings Ltd operates in the analytical science industry. The group operates in two segments namely, Analytical Products which design, manufacture, distribute, and sale of Analytical components and consumables, and Life Science Solutions which design, manufacture, distribute, and sale of pathology, automation workflow solutions, microsampling devices, testing, and data analysis. The majority of its revenue is derived from developing and manufacturing a range of precision consumable components and solutions. It operates predominantly in Malaysia, Japan, Australia, New Zealand, the USA, Europe, the Middle East, India and African countries.

Trajan Group Holdings (ASX:TRJ) Headlines

No Headlines